- COVID-19 is primarily infecting older patients with comorbid conditions such as diabetes and cardiac disease.
- Children so far have experienced milder symptoms.
- Pregnant women who have been infected have also had a milder effect.
- The median duration between onset of symptoms and admission to the ICU is around 9 to 10 days.
- Primary reasons for ICU admission have been respiratory support. Two-thirds of patients have met the criteria for ARDS.
- Rapid access to diagnostic testing continues to be a priority as it enables clinicians to take action and implement infection control practices.
- The principal feature of those suffering from serious disease from COVID-10 is the development of ARDS.
- Treatment strategies for such patients include conservative fluid strategies for patients without shock following initial resuscitation, early antibiotics if bacterial co-infection is suspected, lung-protective ventilation, prone positioning, and ECMO for refractory hypoxaemia.
- Septic shock and specific organ dysfunction are also being observed in a significant proportion of patients with COVID-19-related critical illness.
- A large majority of severely affected patients have received targeted therapies, including neuraminidase inhibitors and corticosteroids.
- Mortality among all infected patients remains between 0.5% to 4%, but among those who have to be hospitalised, mortality is around 5 to 15%. Mortality rates are between 22 to 62% among those who become critically ill.
- The exact cause of death remains unknown, but presumed reasons include progressive hypoxia and multiorgan dysfunction.
- Additional critical care strategies are also being implemented including admission of patients with suspected infection to private rooms, use of face masks during assessment and transfer, maintaining a distance of at least 2 m between patients, extra caution when using high-flow nasal oxygen or non-invasive ventilation, and additional airborne precautions including N95 respirators and eye protection.
- Critical care facilities are also ensuring their staff receives updated training in infection prevention and control, including the use of protective equipment.
#CoronavirusOutbreak: Caring for the Critically Ill - Trends, Treatment and Mortality
«« Allocating Ventilators in a Pandemic
COVID-19 Pandemic: Salute to the Healthcare Soldiers »»
Published on : Mon, 16 Mar 2020
HAMILTON-MR1. Intelligent ventilation from the ICU to MRI
The HAMILTON-MR1 has been especially developed for the MRI suite. The ICU ventilator combines reliability, compact size, and high performance with patient-adaptive modes that support advanced lung-protective strategies. It is the ideal choice for transporting...
Heart & Lung Therapies
ECLS with Xenios console The Xenios console is the core of our extracorporeal life support (ECLS) offering. The console, equipped with the right patient kit and cannulas, determines the type of extracorporeal treatment. One console – different...
Stat Profile Prime® CCS Analyzer
The New Definition of Simplicity for Critical Care Testing Measures: pH PCO 2 PO 2 Na K Cl iCa Glu Lac Hct Stat Profile Prime combines the revolutionary microelectronics
Fingerstick Capillary Blood Testing for Lactate, Hb, and Hct The StatStrip Lactate and Hemoglobin/Hematocrit Meter system (StatStrip LAC/Hb/Hct) is a handheld, easy-to-use meter system that measures LAC, Hb and Hct at the point-of-care using...
StatSensor® and StatSensor Xpress™ Creatinine and eGFR Meters
StatSensor Xpress Creatinine is not available in the U.S. or Canada The StatSensor Creatinine Hospital Meter System is a handheld analyzer and miniaturized, single-use biosensor for whole blood creatinine testing. StatSensor Creatinine incorporates...